Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Amplify Therapeutics ApS
APS
Active
CVR 43803999
Ole Maaløes Vej 3
Manufacture of pharmaceutical preparations · NACE 2120
Est. 2023
1 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK 926K
-119% vs 2024
EBITDA margin
-416.8%
+53% vs 2024
Equity ratio
-370.0%
Financial strength
Net profit 2025
DKK -3,3M
+54% vs 2024
EBITDA — year on year
DKK millions
0M
-1M
-1M
-2M
-3M
-2M
2023
-8M
-300%
2024
-4M
+50%
2025
Key figures
Annual report 2025
Revenue
DKK 926K
-119%
EBITDA
DKK -3,9M
+53%
Net profit
DKK -3,3M
+54%
Total assets
DKK 3,4M
-43%
Equity
DKK -12,4M
-37%
Employees
1
—
Company information
Legal name
Amplify Therapeutics ApS
CVR number
43803999
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
23. januar 2023
Share capital
DKK 40.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem eller af den samlede bestyrelse
Company purpose
Selskabets formål er forskning, udvikling og kommercialisering af lægemidler
Contact
Address
Ole Maaløes Vej 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Manufacture of pharmaceutical preparations
Companies in København
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
-2M
2023
-5M
2024
1M
2025
EBITDA
DKK millions
0M
-1M
-1M
-2M
-2M
-2M
2023
-8M
2024
-4M
2025
Income statement
DKK thousands
Item
2023
2024
2025
Revenue
-1.559
-4.962
926
Staff expenses
-825
-3.319
-4.786
EBITDA
-2.384
-8.280
-3.860
Depreciation & amort.
-0
-0
-0
EBIT
-2.384
-8.280
-3.860
Net financials
-95
-497
-845
Profit before tax
-2.479
-8.777
-4.705
Tax
-526
-1.583
-1.369
Net profit
-1.953
-7.195
-3.336
Balance sheet
DKK thousands
Item
2023
2024
2025
Total assets
2.630
5.945
3.363
Equity
-1.913
-9.108
-12.443
Long-term debt
4.098
14.597
15.448
Short-term debt
445
455
358
Total debt
4.542
15.052
15.806
Financial ratios
5-year trend
EBITDA margin
-416.8%
This company
15.8%
Market median
-2738% vs market
2023
2025
Equity ratio
-370.0%
This company
38.2%
Market median
-1069% vs market
2023
2025
Return on equity
-333584400.0%
This company
18.4%
Market median
-1812958796% vs market
2023
2025
Net profit margin
-360.3%
This company
8.1%
Market median
-4548% vs market
2023
2025
Asset turnover
0.28×
This company
1.12×
Market median
-75% vs market
2023
2025
Debt / equity
1.27×
This company
0.62×
Market median
-105% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-23 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
TK
Thomas Kirkegaard Jensen
Management
Management
2023
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
AV
Anders Vadsholt
Board of Directors
2023
—
—
AM
Anders Mørkeberg Hinsby
Chairman
2023
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Dare to Dream ApS
Company
33.3%
33.3%
2023
WoB Holding ApS
Company
25.0%
25.0%
2023
Alpha Healthcare Investments ApS
Company
25.0%
25.0%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Alpha Healthcare Investments ApS
Amplify Therapeutics ApS
(this company)
Board network connections
Board members of Amplify Therapeutics ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Thomas Kirkegaard Jensen
Management
0 companies
Anders Vadsholt
Board of Directors
0 companies
Anders Mørkeberg Hinsby
Chairman
0 companies